Journals / Turkish Journal of Analytical Chemistry / 2023 / Cilt: 5 Sayı: 1

Determination of cytotoxic, anti-acetylcholinesterase and antioxidant activity of some medicinal Artemisia spp.

Pages
1–10
Publication Date
2023-06-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was determined that demonstrated the selective effect of A. dracunculus and A. dracunculoides on the cytotoxicity of A549 and hGF cells.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The study aims to investigated the antioxidant activities, phenolic compounds, acetylcholinesterase enzyme inhbition and cytotoxic effects of two different of Artemisia spp. (Artemisia dracunculus L. and Artemisia dracunculoides Pursh) cultivated in Turkey organically, for the first time.
📊
Key Findings & Data:And also acetylcholinesterase enzyme inhibition activity and anti-cancer activity in-vitro aganist human melanoma (VMM917, CRL-3232), lung carcinoma (A549, CCL-185) and, normal human fibroblast (hGF, PCS-201-018) cells were studied.
💡
Conclusion & Impact:It was determined that demonstrated the selective effect of A. dracunculus and A. dracunculoides on the cytotoxicity of A549 and hGF cells.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Artemisia dracunculus · Artemisia dracunculoides · acetylcholinesterase

Abstract

The study aims to investigated the antioxidant activities, phenolic compounds, acetylcholinesterase enzyme inhbition and cytotoxic effects of two different of Artemisia spp. (Artemisia dracunculus L. and Artemisia dracunculoides Pursh) cultivated in Turkey organically, for the first time. Total phenolic, total flavonoid contents of the plants determined spectrophotometrically while antioxidant activity DPPH, CUPRAC, and FRAP was determined using colorimetric method. And also acetylcholinesterase enzyme inhibition activity and anti-cancer activity in-vitro aganist human melanoma (VMM917, CRL-3232), lung carcinoma (A549, CCL-185) and, normal human fibroblast (hGF, PCS-201-018) cells were studied. Total phenolic (225-324 mgGAE/g sample) and total flavonoid contents (0.066-0.085 mgQAE/g sample), antioxidant activity (DPPH (1.371-1.655 mg/mL), CUPRAC (0.246-0.344 µM CTEAC) and FRAP (462.133-726.661 µM CTEAC)). A. dracunculus and A. dracunculoides extracts inhibited 40.09±0.65%, and 39.48±3.68% of acetylcholinesterase activity. It was determined that demonstrated the selective effect of A. dracunculus and A. dracunculoides on the cytotoxicity of A549 and hGF cells.

🔖

Cite This Article

CAN, Z., DEMİR, E. A., AKAR, Z., KARA, Y., GIDIK, B. (2023). Determination of cytotoxic, anti-acetylcholinesterase and antioxidant activity of some medicinal Artemisia spp.. Turkish Journal of Analytical Chemistry, Cilt: 5 Sayı: 1, 1–10. https://ajindex.com/articles/946930

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. M. Willcox, Artemisia species: from traditional medicines to modern antimalarials-and back again J Altern Complem Med, 15, 2009, 101–109
  2. B. Koul, P, Taak, The Artemisia genus: a review on traditional uses, phytochemical constituents, pharmacological properties and germplasm conservation. JGL. 7(1):1000142. 2017
  3. H. Ekiert, J. Swiatkowska, E. Knut, P. Klin, A. Rzepiela, M. Tomczyk, A. Szopa, Artemisia dracunculus (Tarragon): A Review of Its Traditional Uses, Phytochemistry and Pharmacology. Frontiers in Pharacol, 14. 2021
  4. R. Phillips, N. Foy, Herbs. Pan Books Ltd., London, pp. 1990, 171–178
  5. G. Haghi, F. Ghasian, J. Safaei-Ghomi, Determination of the essential oil from root and aerial parts of Artemisia dracunculus L. cultivated in central Iran, J Essential Oil Res, 22, 2010, 294–296
  6. E.M. Suleimenov, A.V. Tkachev, S.M. Adekenov, Essential oil from Kazakhstan Artemisia species. Chem, Nat Compd, 46(1), 2010, 135–139
  7. I. Tak, D. Mohiuddin, B.A. Ganai, M.Z. Chishti, F. Ahmad, J.S. Dar, Phytochemical studies on the extract and essential oils of Artemisia dracunculus L. (tarragon), Afr J Plant Sci, 8(10), 2014, 72–75
  8. S. Weinoehrl, B. Feistel, I. Pischel, B. Kopp, V. Butterweck, Comparative evaluation of two different Artemisia dracunculus L. cultivars for blood sugar lowering effects in rats, Phytother Res, 26, 2012, 625–629
  9. T. Daly, M.A. Jiwan, N.M. O’Brien, S.A. Aherne, Carotenoid content of commonly consumed herbs and assessment of their bioaccessibility using an in vitro digestion model, Plant Food Hum Nutr, 65, 2010, 164–169
  10. D. Obolskiy, I. Pischel, B. Feistel, N. Glotov, M. Heinrich, Artemisia dracunculus L. (tarragon): A critical review of its traditional use, chemical composition, pharmacology, and safety, J Agric Food Chem, 59, 2011, 11367–11384
  11. G. ZawiĞlak, K. Dzida, Composition of essentials oils and content of macronutrients in herbage of tarragon (Artemisia dracunculus L.) grown in south-eastern Poland, J Elementol, 4, 2012, 721–729
  12. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, M.J. Thun, Cancer Statistics, CA Cancer J Clin, 58(2), 2008, 71–96
  13. R.T. Skeel, Handbook of cancer chemotherapy. Lippincott Williams and Wilkins, Philadelphia, 2003
  14. S. Duangmano, P. Sae-Lim, A. Suksamrarn, F.E. Domann, P. Patmasiriwat, B. Cucurbitacin, Inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation, BMC Complement